Adjuvant therapies for HIV-associated neurocognitive disorders

OBJECTIVE: HIV-associated neurocognitive disorder (HAND) is a frequent and heterogeneous complication of HIV, affecting nearly 50% of infected individuals in the combined antiretroviral therapy (cART) era. This is a particularly devastating statistic because the diagnosis of HAND confers an increase...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Jennifer L, Barrett, Jeffrey S, Vezina, Heather E, Spitsin, Sergei, Douglas, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265066/
https://www.ncbi.nlm.nih.gov/pubmed/25540809
http://dx.doi.org/10.1002/acn3.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265066/
https://www.ncbi.nlm.nih.gov/pubmed/25540809
http://dx.doi.org/10.1002/acn3.131

Ejemplares similares